Litigation Details for AMGEN INC. v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2020)
✉ Email this page to a colleague
AMGEN INC. v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2020)
Docket | ⤷ Try a Trial | Date Filed | 2020-01-20 |
Court | District Court, D. New Jersey | Date Terminated | 2020-05-08 |
Cause | 35:271 Patent Infringement | Assigned To | Freda L. Wolfson |
Jury Demand | None | Referred To | Tonianne J. Bongiovanni |
Patents | 7,361,649; 7,361,650; 7,867,996; 7,879,842 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in AMGEN INC. v. ZYDUS PHARMACEUTICALS (USA) INC.
Details for AMGEN INC. v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2020-01-20 | 1 | Complaint | expiration of U.S. Patent Nos. 7,361,649 (“the ’649 Patent”), 7,361,650 (“the ’650 Patent”), 7,867,996 (“…CERTIFICATION U.S. Patent Nos. 7,361,649 (“the ’649 Patent”), 7,361,650 (“the ’650 Patent”), 7,867,996 (… COUNT I: INFRINGEMENT OF U.S. PATENT NO. 7,361,649 Plaintiffs hereby reallege…(“the ’996 Patent”), and 7,879,842 (“the ’842 Patent”) (collectively, “the Patents-in-Suit”). … This is a civil action for patent infringement arising under the patent laws of the United States, | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |